Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Smoking Cessation 3Neoplasms 2Alcohol Drinking 2Urinary Bladder Neoplasms 1Smoking 1Postoperative Complications 1Lung Neoplasms 1HIV Infections 1Cigarette Smoker 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma of Lung 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 93Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 51Doxorubicin 50atezolizumab 48trametinib 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Smoking Devices × Clear all
NCT05941858 2026-04-02

Online Tai Chi Intervention to Promote Smoking Cessation Among Cancer Survivors

Ohio State University Comprehensive Cancer Center

Phase NA Completed
68 enrolled

Neoplasms, Smoking Cessation

NCT03668769 2024-02-23

Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit Smoking

M.D. Anderson Cancer Center

Phase NA Withdrawn
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡